Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

FGFR3 mutations and a normal CK20 staining pattern define low-grade noninvasive urothelial bladder tumours.

European urology - 1 Sept 2007

van Oers Johanna M M, Wild Peter J, Burger Maximilian, Denzinger Stefan, Stoehr Robert, Rosskopf Elke, Hofstaedter Ferdinand, Steyerberg Ewout W, Klinkhammer-Schalke Monika, Zwarthoff Ellen C, van der Kwast Theodorus H, Hartmann Arndt

Abstract excerpt

OBJECTIVES: Molecular markers superior to conventional clinicopathologic parameters are needed to predict disease courses in bladder cancer patients. In this study, we investigated four markers (Ki-67, TP53, CK20, FGFR3) in primary urothelial bladder tumours and compared them with traditional pathologic features. METHODS: Tissue microarrays were used to analyse CK20, TP53, and Ki-67 expression...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Papillary
Share to DNA, Neoplasm

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Follow-Up Studies

Share to Ki-67 Antigen

Share to Neoplasm Staging

Share to Receptor, Fibroblast Growth Factor, Type 3

Share to Tumor Suppressor Protein p53

Share to Urinary Bladder Neoplasms

Source

Identifiers

PMID: 17240035
DOI: 10.1016/j.eururo.2007.01.009

Genes

FGFR3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

FGFR3 mutations and a normal CK20 staining pattern define low-grade noninvasive urothelial bladder tumours.PMID 17240035Read ↗

Reassessment of p53 immunohistochemistry thresholds in invasive high grade bladder cancer shows a better correlation with TP53 and FGFR3 mutations.Semantic proximity Read ↗

FGFR3 and TP53 gene mutations define two distinct pathways in urothelial cell carcinoma of the bladder.Semantic proximity Read ↗

Molecular profiling of bladder tumors based on the detection of FGFR3 and TP53 mutations.Semantic proximity Read ↗

Diagnostic and Prognostic Implications of FGFR3high/Ki67high Papillary Bladder Cancers.Semantic proximity Read ↗

FGFR3 and Tp53 mutations in T1G3 transitional bladder carcinomas: independent distribution and lack of association with prognosis.Semantic proximity Read ↗

Prediction of progression of non-muscle-invasive bladder cancer by WHO 1973 and 2004 grading and by FGFR3 mutation status: a prospective study.Semantic proximity Read ↗

FGFR3 and p53 protein expressions in patients with pTa and pT1 urothelial bladder cancer.Semantic proximity Read ↗

Prognostic markers in invasive bladder cancer: FGFR3 mutation status versus P53 and KI-67 expression: a multi-center, multi-laboratory analysis in 1058 radical cystectomy patients.Semantic proximity Read ↗

The FGFR3 mutation is related to favorable pT1 bladder cancer.Semantic proximity Read ↗

Role of activating fibroblast growth factor receptor 3 mutations in the development of bladder tumors.Semantic proximity Read ↗

FGFR3, HRAS, KRAS, NRAS and PIK3CA mutations in bladder cancer and their potential as biomarkers for surveillance and therapy.Semantic proximity Read ↗

The Emerging Molecular Landscape of Urothelial Carcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.